After Glenmark, Dr Reddy’s Launches Favipiravir For Indian Market
Pfizer, Novartis and Mylan Announce Further Measures To Tackle The Pandemic
While Dr Reddy’s partners with Fujifilm Toyama for favipiravir for the Indian market, Pfizer and Gilead join together to increase the manufacturing and supply of investigational antiviral treatment remdesivir. Mylan donates a million dollars to Sesame Workshop to provide socio-emotional support to children and families to cope with the uncertainties caused by COVID-19, while Glenmark introduces a higher strength of Fabiflu for the Indian market.
